Pfizer

“The gold rush led by Big Pharma and investors has ended. The market is punishing developers whose drugs fail to stand out, and pipelines are being trimmed. Pfizer just axed another program from its massive Metsera deal, while peers like Amgen have begun trimming their own early-stage pipelines.”

“We know for a fact that a lot of Chinese leaders were not taking the Chinese vaccine, but they ended up taking, quietly, Pfizer, Moderna, et cetera. And they couldn't export this vaccine”